Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
15.01
-0.24 (-1.57%)
At close: Jan 30, 2026, 4:00 PM EST
15.02
+0.01 (0.07%)
After-hours: Jan 30, 2026, 7:14 PM EST

Eton Pharmaceuticals Revenue

Eton Pharmaceuticals had revenue of $22.46M in the quarter ending September 30, 2025, with 117.54% growth. This brings the company's revenue in the last twelve months to $70.32M, up 102.77% year-over-year. In the year 2024, Eton Pharmaceuticals had annual revenue of $39.01M with 23.29% growth.

Revenue (ttm)
$70.32M
Revenue Growth
+102.77%
P/S Ratio
5.70
Revenue / Employee
$2,268,258
Employees
31
Market Cap
402.53M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202439.01M7.37M23.29%
Dec 31, 202331.64M10.39M48.90%
Dec 31, 202221.25M-581.00K-2.66%
Dec 31, 202121.83M21.79M55,879.49%
Dec 31, 202039.00K-920.00K-95.93%
Dec 31, 2019959.00K--
Dec 31, 2018---
Dec 31, 2017---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition